Prof Alain Dupuy is an expert in Dermatology at Centre Hospitalier Universitaire de Rennes (France). Alain Dupuy has authored 404 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 1 of them ongoing. SLR score: 1,112 (community average: 125). How the SLR is computed.

LeadR Profile

1 112 ScienceLeadR Reputation 1112
Network Map

Dermatology

Subspecialties: Oncology - Immunology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1989 - 2026

Source: PubMed

l'Hôpital Pontchaillou

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study.
PMID 42791653 — cells, merkel cells, somatostatin, neoplasms, therapeutics, dermatology, carcinoma, merkel cell
Cancer Med20260
A New Phototherapy Regimen Coupled with Oral Vitamin D Supplementation, for the Long-Term Control of Atopic Dermatitis: A French Multicenter, Randomized, Crossover, Pragmatic Trial.
PMID 42728529 — vitamin d, dermatitis, vitamins, phototherapy, genes, tat, therapeutics, dermatitis, atopic
Dermatol Ther (Heidelb)20260
Skin lesions revealing a loco-regional and systemic metallosis.
PMID 42183096 — skin, wounds and injuries
JAAD Case Rep20260
Real-World Use of Dupilumab in Atopic Dermatitis: Observational Study Results Linked to SNDS.
PMID 41649792 — dermatitis, contraindications, cyclosporine, pharmacology, therapeutics, dermatitis, atopic, snds
Fundam Clin Pharmacol20260
Real-world outcomes of adjuvant therapies in stage III/IV melanoma: Insights from the French RIC-MEL cohort.
PMID 41086101 — sexually transmitted diseases, melanoma, skin diseases, therapeutics
J Eur Acad Dermatol Venereol20250

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 3 4
Phase 2 3
N/A 2
Phase 4 2
Phase 2/Phase 3 1

By status:

Completed 9
Recruiting 2
Active not recruiting 1

By type:

Interventional 10
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 2
multicentric5to9 1
multicentricup10 6

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

LeadR Networks

Main global connection map